| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net change in cash and cash equivalents | 4,518 | 10,611 |
| Cash and cash equivalents at beginning of period | 94,851 | - |
| Cash and cash equivalents at end of period | 99,369 | - |
TENAX THERAPEUTICS, INC. (TENX)
TENAX THERAPEUTICS, INC. (TENX)